Meeting Overview - The 11th meeting of the 11th Board of Directors of Wento Holdings Co., Ltd. was held on January 27, 2026, at 9:30 AM, combining on-site and remote voting [2] - The meeting was chaired by Chairman Xu Jian, with all 9 directors present, including those attending via remote voting [2] Resolutions Passed - The Board approved the revision of the "Working Rules of the Audit Committee" [3] - The Board approved the revision of the "Working Rules of the Strategic Committee" [5] - The Board approved the revision of the "Working Rules of the Nomination Committee" [7] - The Board approved the revision of the "Working Rules of the Compensation and Assessment Committee" [9] - The Board approved the revision of the "Independent Director System" [11] - The Board approved the revision of the "Information Disclosure Management System" [14] - The Board approved the revision of the "Insider Information Knowledge Person Registration Management System" [16] - The Board approved the establishment of the "Public Opinion Management System" [18] - The Board approved the establishment of the "Market Value Management System" [20] Voting Results - All resolutions received unanimous approval with 9 votes in favor, 0 against, and 0 abstentions [4][6][8][10][13][15][17][19][21]

Core Viewpoint - The company reported a significant increase in revenue for the first three quarters of 2025, driven by domestic insulin product sales and international market expansion. Financial Performance - For the first three quarters of 2025, the company's revenue reached 3.047 billion yuan, an increase of 802 million yuan, representing a year-on-year growth of 35.73% [6] - Domestic insulin product sales contributed 2.624 billion yuan, up 822 million yuan from the previous year, with volume and price increases contributing 492 million yuan and 330 million yuan respectively [6][7] - International sales revenue was 353 million yuan, a year-on-year increase of 110 million yuan, or 45.52%, attributed to the company's global strategy and partnerships, particularly in Brazil [6][8] Non-Recurring Gains and Losses - The report indicates that there were non-recurring gains and losses, but specific details on amounts and classifications were not provided [4] Shareholder Information - The company will hold its first extraordinary general meeting of 2025 on November 17, 2025, with both onsite and online voting options available for shareholders [14][15] Governance Changes - The company plans to cancel its supervisory board and amend its articles of association, with the audit committee taking over the supervisory responsibilities [53][54] - The company has proposed updates to its operational scope, including new business areas such as rubber products and medical packaging [55]